157 related articles for article (PubMed ID: 12558967)
1. Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes.
Subasinghe S; Unabia S; Barrow CJ; Mok SS; Aguilar MI; Small DH
J Neurochem; 2003 Feb; 84(3):471-9. PubMed ID: 12558967
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine.
Mok SS; Turner BJ; Beyreuther K; Masters CL; Barrow CJ; Small DH
Eur J Biochem; 2002 Jun; 269(12):3014-22. PubMed ID: 12071966
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant.
Muñoz FJ; Opazo C; Gil-Gómez G; Tapia G; Fernández V; Valverde MA; Inestrosa NC
J Neurosci; 2002 Apr; 22(8):3081-9. PubMed ID: 11943811
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.
Mendoza-Oliva A; Ferrera P; Fragoso-Medina J; Arias C
CNS Neurosci Ther; 2015 Aug; 21(8):631-41. PubMed ID: 26096465
[TBL] [Abstract][Full Text] [Related]
5. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
7. Study of beta-amyloid peptide (Abeta40) insertion into phospholipid membranes using monolayer technique.
Ji SR; Wu Y; Sui SF
Biochemistry (Mosc); 2002 Nov; 67(11):1283-8. PubMed ID: 12495427
[TBL] [Abstract][Full Text] [Related]
8. The effect of cholesterol and monosialoganglioside (GM1) on the release and aggregation of amyloid beta-peptide from liposomes prepared from brain membrane-like lipids.
Tashima Y; Oe R; Lee S; Sugihara G; Chambers EJ; Takahashi M; Yamada T
J Biol Chem; 2004 Apr; 279(17):17587-95. PubMed ID: 14709559
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice.
Burns MP; Igbavboa U; Wang L; Wood WG; Duff K
Neuromolecular Med; 2006; 8(3):319-28. PubMed ID: 16775383
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.
Buxbaum JD; Cullen EI; Friedhoff LT
Front Biosci; 2002 Apr; 7():a50-9. PubMed ID: 11900994
[TBL] [Abstract][Full Text] [Related]
11. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes.
Thyberg J
J Histochem Cytochem; 2002 Feb; 50(2):185-95. PubMed ID: 11799137
[TBL] [Abstract][Full Text] [Related]
12. Location and conformation of amyloid β(25-35) peptide and its sequence-shuffled peptides within membranes: implications for aggregation and toxicity in PC12 cells.
Tsai HH; Lee JB; Shih YC; Wan L; Shieh FK; Chen CY
ChemMedChem; 2014 May; 9(5):1002-11. PubMed ID: 24729535
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of statins in an in vitro model of Alzheimer's disease.
Fonseca AC; Proença T; Resende R; Oliveira CR; Pereira CM
J Alzheimers Dis; 2009; 17(3):503-17. PubMed ID: 19363255
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer.
Yu X; Zheng J
J Mol Biol; 2012 Aug; 421(4-5):561-71. PubMed ID: 22108168
[TBL] [Abstract][Full Text] [Related]
15. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
[TBL] [Abstract][Full Text] [Related]
16. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides.
Arispe N; Doh M
FASEB J; 2002 Oct; 16(12):1526-36. PubMed ID: 12374775
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol oxidase and the hydroxymethylglutaryl coenzyme A reductase inhibitor mevinolin perturb endocytic trafficking in cultured vascular smooth muscle cells.
Thyberg J
J Submicrosc Cytol Pathol; 2003 Oct; 35(4):457-68. PubMed ID: 15137687
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
Chen H; Xing Y; Liu R
Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
[TBL] [Abstract][Full Text] [Related]
20. Examining the levels of ganglioside and cholesterol in cell membrane on attenuation the cytotoxicity of beta-amyloid peptide.
Lin MS; Chen LY; Wang SS; Chang Y; Chen WY
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):172-7. PubMed ID: 18514493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
